Complement Genomics

Pre-clinical

Lanchester, County Durham, United KingdomFounded 2000compgeno.com

Complement Genomics is a long-established, accredited DNA testing company that began with a vision to make DNA testing accessible to the public. Over two decades, it has expanded from paternity testing into diverse areas including pharmacogenetics for clinical trials, wildlife genetics, and COVID-19 testing. The company operates from its own state-of-the-art facility, the Durham Genome Centre, and is led by a small, dedicated management team focused on applying genomic expertise across multiple sectors.

Founded

2000

Focus

Genetics & Genomics

AI Company Overview

Technology Platform

A versatile genomics services platform utilizing accredited laboratories for Next-Generation Sequencing (NGS), Quantitative PCR (Q-PCR), Digital PCR, genotyping, and biobanking, applied across human, animal, and plant DNA testing.

Opportunities

Growth opportunities include expanding its pharmacogenetics services for the growing personalized medicine market, developing new direct-to-consumer or veterinary genetic tests, and leveraging its NGS and PCR infrastructure for new diagnostic service lines in areas like rare diseases or oncology.

Its accreditation and agile lab model position it well for partnership-based white-label services.

Risk Factors

Key risks include reliance on niche, competitive markets (paternity testing), the need for continuous capital investment to keep pace with genomic technology, dependence on maintaining critical laboratory accreditations (UKAS, Ministry of Justice), and the post-pandemic wind-down of its COVID-19 testing revenue stream.

A very small identified leadership team also presents a key-person risk.

Competitive Landscape

Competes with large direct-to-consumer genetics firms (e.g., AncestryDNA) in relationship testing, global CROs (e.g., LabCorp) in clinical trial services, and specialized labs in wildlife genetics. Its differentiation lies in its unique combination of UK legal accreditation, broad technical expertise across human/animal genetics, and ownership of an agile, accredited laboratory facility.